NEW YORK, May 1, 2018 /PRNewswire/ -- The Centers of Psychiatric Excellence (COPE) is pleased to present new research onthe drug ketamine at The American Psychiatric Association's (APA) Annual Meeting in New York, NY, on Monday, May 7. The presentations will take place from 1:00 – 4:00
COPE's session is called "Advances in Ketamine Research and Clinical Practice: Need for Evidence-Based Practice Guidelines" and will include the following presentations:
Chair: Steven Szabo, M.D. (Duke University)
"Studies show overwhelming evidence to support the efficacy of ketamine in the most difficult to treat cases of major depression, anxiety, bipolar depression, chronic pain and opioid addiction," said Dr. Prakash Masand, CEO of Centers of Psychiatric Excellence (COPE) and Adjunct Professor, Duke-NUS. "We are excited to share this important information at this year's APA annual meeting."
For more information about COPE's session on Ketamine, visit https://www.copepsychiatry.com/advances-in-ketamine-research-and-clinical-practice-need-for-evidence-based-practice-guidelines/
About COPE COPE (Centers of Psychiatric Excellence) is a management services organization that offers administrative and advisory support to independently operated psychiatric treatment clinics. COPE is proud to partner with highly specialized clinics around the country that service the most difficult to treat cases of depression, anxiety (specifically PTSD), and chronic pain.
COPE was founded by three internationally renowned psychiatrists at Duke University Medical Center: Prakash Masand, MD; Ashwin Patkar, MD; and Steven Szabo, MD. In their more than 60 years of clinical and academic experience, they saw a clear, unmet need to provide support and services to facilities that offer evidence-based, innovative treatment.You can visit https://www.copepsychiatry.com/
Media Contact Prakash Masand MD 919-619-5101 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/centers-of-psychiatric-excellence-cope-to-present-new-research-on-ketamine-at-the-american-psychiatric-associations-annual-meeting-in-new-york-city-on-may-7-300640257.html
SOURCE Centers of Psychiatric Excellence
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All